Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies

Trends in Molecular Medicine

Volumn 21, Issue 7, 2015, Pages 408-416

  Fischer, Alain ^a,b,c,d  

^a PARIS DESCARTES SORBONNE PARIS CITÉ UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM   (France)

^d l'alimentation et l'Environnement   (France)

Author keywords

Autoimmunity; Inflammation; Innate immunity; Primary immunodeficiencies; T lymphocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CELL AGING; DEVELOPMENTAL DISORDER; EFFECTOR CELL; GENETIC DISORDER; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; MEMORY T LYMPHOCYTE; PRIMARY T CELL IMMUNODEFICIENCY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; INNATE IMMUNITY;

ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES; T-LYMPHOCYTES;

EID: 84933677035     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2015.04.002     Document Type: Review

References (99)

1. Fairfax B.P., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014, 343:1246949.
2. Lee M.N., et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014, 343:1246980.
3. Picard C., et al. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur. J. Immunol. 2014, 44:2854-2861.
4. Casanova J.L., et al. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 2014, 211:2137-2149.
5. Al-Herz W., et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front. Immunol. 2014, 5:162.
6. Fischer A., et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 2005, 203:98-109.
7. Kwan A., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. J. Am. Med. Assoc. 2014, 312:729-738.
8. Aiuti A., et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 2009, 360:447-458.
9. Hacein-Bey-Abina S., et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2014, 371:1407-1417.
10. Dickinson R.E., et al. The evolution of cellular deficiency in GATA2 mutation. Blood 2014, 123:863-874.
11. Spinner M.A., et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2014, 123:809-821.
12. Pannicke U., et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat. Genet. 2009, 41:101-105.
13. Lagresle-Peyrou C., et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat. Genet. 2009, 41:106-111.
14. Armanios M., et al. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
15. Walne A.J., et al. Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am. J. Hum. Genet. 2013, 92:448-453.
16. Le Guen T., et al. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum. Mol. Genet. 2013, 22:3239-3249.
17. Anderson B.H., et al. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat. Genet. 2012, 44:338-342.
18. Villard J., et al. MHC class II deficiency: a disease of gene regulation. Medicine 2001, 80:405-418.
19. Villa-Forte A., et al. HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum. 2008, 58:2579-2582.
20. Liu Y., et al. Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum. 2012, 64:895-907.
21. Notarangelo L.D. Functional T cell immunodeficiencies (with T cells present). Annu. Rev. Immunol. 2013, 31:195-225.
22. Arnaiz-Villena A., et al. Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor. N. Engl. J. Med. 1992, 327:529-533.
23. Hauck F., et al. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J. Allergy Clin. Immunol. 2012, 130:1144-1152.
24. 2+ regulation of immunity against Epstein-Barr virus. Blood 2014, 123:2148-2152.
25. Crequer A., et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J. Clin. Invest. 2012, 122:3239-3247.
26. Feske S., et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185.
27. Picard C., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 2009, 360:1971-1980.
28. Chen L., et al. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242.
29. Salzer E., et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2013, 98:473-478.
30. van Montfrans J.M., et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 2012, 129:787-793.
31. Palendira U., et al. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 2011, 9:e1001187.
32. Byun M., et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J. Exp. Med. 2013, 210:1743-1759.
33. Pearce E.L., et al. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
34. Martin E., et al. CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Nature 2014, 510:288-292.
35. Skon C.N., et al. Fox factors fight over T cell quiescence. Nat. Immunol. 2011, 12:522-524.
36. Abdollahpour H., et al. The phenotype of human STK4 deficiency. Blood 2012, 119:3450-3457.
37. Nehme N.T., et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 2012, 119:3458-3468.
38. Albert M.H., et al. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr. Opin. Hematol. 2011, 18:42-48.
39. Zhang Q., et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 2009, 361:2046-2055.
40. Zhang Q., et al. DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J. Exp. Med. 2014, 211:2549-2566.
41. Courtois G., et al. A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest. 2003, 112:1108-1115.
42. Doffinger R., et al. X-linked ectodermal dysplasia anhydrotic and immunodeficiency is caused by hypo-functional NEMO mutations. Nat. Genet. 2001, 27:277-285.
43. Greil J., et al. Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. J. Allergy Clin. Immunol. 2013, 131:1376-1383.
44. Jabara H.H., et al. A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. J. Allergy Clin. Immunol. 2013, 132:151-158.
45. Pannicke U., et al. Deficiency of innate and acquired immunity caused by an IKBKB mutation. N. Engl. J. Med. 2013, 369:2504-2514.
46. Torres J.M., et al. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity. J. Clin. Invest. 2014, 124:5239-5248.
47. Turvey S.E., et al. The CARD11-BCL10-MALT1 (CBM) signalosome complex: stepping into the limelight of human primary immunodeficiency. J. Allergy Clin. Immunol. 2014, 134:276-284.
48. Willmann K.L., et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat. Commun. 2014, 5:5360.
49. Salzer E., et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy Clin. Immunol. 2014, 133:1651-1659.
50. Kotlarz D., et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 2013, 210:433-443.
51. Bustamante J., et al. Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin. Immunol. 2014, 26:454-470.
52. Milner J.D., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
53. Minegishi Y., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
54. Liu L., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 2011, 208:1635-1648.
55. Puel A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
56. Boisson B., et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 2013, 39:676-686.
57. Puel A., et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 2010, 207:291-297.
58. de Saint Basile G., et al. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat. Rev. Immunol. 2010, 10:568-579.
59. Stepensky P., et al. Early-onset Evans syndrome, immunodeficiency and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood 2015, 125:753-761.
60. Lu W., et al. Dual proteolytic pathways govern glycolysis and immune competence. Cell 2014, 159:1578-1590.
61. Crow Y.J. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr. Opin. Immunol. 2014, 32C:7-12.
62. Liu Y., et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 2014, 371:507-518.
63. Jeremiah N., et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 2014, 124:5516-5520.
64. Cheng M.H., et al. Monogenic autoimmunity. Annu. Rev. Immunol. 2012, 30:393-427.
65. Nagata S., et al. The Fas death factor. Science 1995, 267:1449-1456.
66. Oliveira J.B., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010, 116:e35-e40.
67. Holzelova E., et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N. Engl. J. Med. 2004, 351:1409-1418.
68. Goodnow C.C. Multistep pathogenesis of autoimmune disease. Cell 2007, 130:25-35.
69. Lohr N.J., et al. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am. J. Hum. Genet. 2010, 86:447-453.
70. Kuehn H.S., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345:1623-1627.
71. Schubert D., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat. Med. 2014, 20:1410-1416.
72. Waterhouse P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
73. Topalian S.L., et al. Balance and imbalance in the immune system: life on the edge. Immunity 2014, 41:682-684.
74. Angulo I., et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science 2013, 342:866-871.
75. Lucas C.L., et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat. Immunol. 2014, 15:88-97.
76. Deau M.C., et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J. Clin. Invest. 2014, 124:3923-3928.
77. Lucas C.L., et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J. Exp. Med. 2014, 211:2537-2547.
78. Berenjeno I.M., et al. PI3K regulatory subunits lose control in cancer. Cancer Cell 2009, 16:449-450.
79. Flanagan S.E., et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat. Genet. 2014, 46:812-814.
80. Milner J.D., et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015, 125:591-599.
81. Haapaniemi E.M., et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 2015, 125:639-648.
82. Ombrello M.J., et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 2012, 366:330-338.
83. Zhou Q., et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 2012, 91:713-720.
84. Snow A.L., et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J. Exp. Med. 2012, 209:2247-2261.
85. Barzaghi F., et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front. Immunol. 2012, 3:211.
86. Ramsdell F., et al. FOXP3 and scurfy: how it all began. Nat. Rev. Immunol. 2014, 14:343-349.
87. + T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer. Sci. Transl. Med. 2013, 5:215ra174.
88. high T cells in human STAT5b deficiency. J. Immunol. 2006, 177:2770-2774.
89. Sharfe N., et al. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3168-3171.
90. Engelhardt K.R., et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J. Allergy Clin. Immunol. 2013, 131:825-830.
91. Alangari A., et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J. Allergy Clin. Immunol. 2012, 130:481-488.
92. Lopez-Herrera G., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am. J. Hum. Genet. 2012, 90:986-1001.
93. Sassi A., et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J. Allergy Clin. Immunol. 2014, 133:1410-1419.
94. Stray-Pedersen A., et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am. J. Hum. Genet. 2014, 95:96-107.
95. Chen R., et al. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J. Allergy Clin. Immunol. 2013, 132:656-664.
96. Fernandez I., et al. Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort. Medicine 2014, 93:e327.
97. Avitzur Y., et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 2014, 146:1028-1039.
98. Lemoine R., et al. Immune deficiency-related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency. J. Allergy Clin. Immunol. 2014, 134:1354-1364.
99. Bigorgne A.E., et al. TTC7A mutations disrupt intestinal epithelial apicobasal polarity. J. Clin. Invest. 2014, 124:328-337.